Electrically conductive polymer nanocomposites have been the subject of intense research due to their promising potential as piezoresistive biomedical sensors, leveraging their flexibility and biocompatibility. Although intrinsically conductive polymers such as polypyrrole (PPy) and polyaniline have emerged as lucrative candidates, they are extremely limited in their processability by conventional solution-based approaches. In this work, ultrathin nanostructured coatings of doped PPy are realized on polyurethane films of different architectures via oxidative chemical vapor deposition to develop stretchable and flexible resistance-based strain sensors. Holding the substrates perpendicular to the reactant flows facilitates diffusive transport and ensures excellent conformality of the interfacial integrated PPy coatings throughout the 3D porous electrospun fiber mats in a single step. This allows the mechanically robust (stretchability > 400%, with fatigue resistance up to 1000 cycles) nanocomposites to elicit a reversible change of electrical resistance when subjected to consecutive cycles of stretching and releasing. The repeatable performance of the strain sensor is linear due to dimensional changes of the conductive network in the low-strain regime (ε ≤ 50%), while the evolution of nano-cracks leads to an exponential increase, which is observed in the high-strain regime, recording a gauge factor as high as 46 at 202% elongational strain. The stretchable conductive polymer nanocomposites also show biocompatibility toward human dermal fibroblasts, thus providing a promising path for use as piezoresistive strain sensors and finding applications in biomedical applications such as wearable, skin-mountable flexible electronics.
Melt electrowriting (MEW) enables precise scaffold fabrication for biomedical applications. With a limited number of processable materials with short and tunable degradation times, polyhydroxyalkanoates (PHAs) present an interesting option. Here, poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHBV) and a blend of PHBV and poly(3‐hydroxybutyrate‐co‐4‐hydroxybutyrate) (PHBV+P34HB) are successfully melt electrowritten into scaffolds with various architectures. PHBV+P34HB exhibits greater thermal stability, making it a superior printing material compared to PHBV in MEW. The PHBV+P34HB scaffolds subjected to enzymatic degradation show tunable degradation times, governed by enzyme dilution, incubation time, and scaffold surface area. PHBV+P34HB scaffolds seeded with human dermal fibroblasts (HDFs), demonstrate enhanced cell adherence, proliferation, and spreading. The HDFs, when exposed to the enzyme solutions and enzymatic degradation residues, show good viability and proliferation rates. Additionally, HDFs grown on enzymatically pre‐incubated scaffolds do not show any difference in behavior compared those grown on control scaffolds. It is concluded that PHAs, as biobased materials with enzymatically tunable degradability rates, are an important addition to the already limited set of materials available for MEW technology.
Multi-layer cell constructs produced in vitro are an innovative treatment option to support the growing demand for therapy in regenerative medicine. Our research introduces a novel construct integrating organ-derived decellularised extracellular matrix (dECM) hydrogels and 3D-printed biodegradable polymer meshes composed of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P34HB) to support and maintain multiple layers of different cell types. We achieved that by integrating the mechanical stability of PHBV+P34HB, commonly used in the food storage industry, with a dECM hydrogel, which replicates organ stiffness and supports cellular survival and function. The construct was customised by adjusting the fibre arrangement and pore sizes, making it a suitable candidate for a personalised design. We showed that the polymer is degradable after precoating it with PHB depolymerase (PhaZ), with complete degradation achieved in 3–5 days and delayed by adding the hydrogel to 10 days, enabling tuneable degradation for regenerative medicine applications. Finally, as a proof of concept, we composed a three-layered tissue in vitro; each layer represented a different tissue type: epidermal, vascular, and subcutaneous layers. Possible future applications include wound healing and diabetic ulcer paths, personalised drug delivery systems, and personalised tissue implants.
Glaucoma, an eye disease causing incremental vision loss, currently has no cure. Its primary cause is the malfunction of the trabecular meshwork (TM), a multilayered tissue in the eye responsible for draining aqueous humor (AH) from the anterior chamber. TM clogging increases outflow resistance, elevates intraocular pressure (IOP), and damages optic nerves, leading to irreversible blindness. Existing in vitro TM models are suboptimal, as they lack the hierarchical structure of the TM. This article introduces a dynamic in vitro TM model, featuring a multilayered scaffold architecture 3D printed via melt electrowriting (MEW), and integrated with a flow system that enables continuous pressure monitoring during perfusion at native flow rates. Printed scaffolds supported the growth of primary adult human TM cells that grew on top and between the fibers. Cellularized scaffolds were tested under static and dynamic conditions. Over 3-5 days, pressure monitoring showed increased outflow resistance due to cell proliferation. Proteomic analysis revealed distinct changes in protein expression related to protein synthesis and respiration of cells grown under flow. Lat-B administration resulted in decreased pressure values and depolymerized actin filaments. These findings suggest that the proposed model is a promising alternative for in vitro glaucoma drug testing. STATEMENT OF SIGNIFICANCE: This study introduces a model of the trabecular meshwork (TM), a tissue in the eye involved in glaucoma, a common eye disease that currently has no cure. Using 3D printing, we created a multilayered scaffold that mimics the structure and function of the human TM. This allows us to study how cells behave and how drugs work under realistic conditions. Unlike existing models, ours accurately replicates all three layers of the TM, providing an advanced dynamic platform for glaucoma research. This innovation could help develop new treatments by offering a more reliable model for testing drugs and understanding how glaucoma works, making a significant impact on eye research.